Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

AccuPlex™ SARS-CoV-2 in Synthetic Oral Fluid

Products are for professional/laboratory use only. AccuPlex™ SARS-CoV-2 in Synthetic Oral Fluid can be utilized for assay verification at installation by documenting test performance along the assay’s range, enabling laboratories to establish lower limits of detection, perform assay comparisons, and evaluate staff proficiency. The product may also be utilized as a quality tool to measure day-to-day performance of the assay. Additional synthetic oral fluid diluent is included to allow additional dilutions as required.

SARS-CoV-2 Accuplex™ solution offers:

  • Non-infectious and replication deficient, enables safe handling in contrast to viral samples 
  • Fully-extractable with a real viral protein coat; superior to “naked” transcribed RNA
  • Includes negative reference material for targeting sequences for the human RNase P gene
  • 2 year stability at 2 – 8°C

Contact us for more information

Click Here >



Request a Quote

Request Quote

Recent Posts

Fungal Infection – Assays and Controls*

IMMY | Vircell IMMY’s rapid fungal assays and Vircell’s external controls deliver reliable, room temperature diagnostics with built-in quality assurance for streamlined serology workflows. Vircell…

Read full article

Vircell – VirClia Extraction Tube

Discover Vircell’s VirClia Extraction Tube, an innovative pre-dispensed tube featuring a one-step filtering process that eliminates the need for centrifugation, thereby significantly simplifying the pre-analytical…

Read full article

Advancing Sepsis Diagnostics—Journal of Clinical Medicine (JCM), Honors SeptiCyte RAPID* Study

  Immunexpress are delighted to announce that the study, “Validation of SeptiCyte® RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation,” has been selected as an Editor’s Choice Paper for 2024 by the Journal of Clinical Medicine (JCM) MDPI Editorial Team. This honour…

Read full article